5-cyclopropyl-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

(3R,3aS,6aS)-5-(tert-Butoxycarbonyl)hexahydro-2H-furo[2,3-c]pyrrole-3-carboxylic acid, 95%, 2g

4-(Pyrrolidin-1-yl)cyclohexan-1-one, 97%, 1g

1-(2-aminoethyl)-5-(3-fluorobenzyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 1g

1-(3-Cyclopropylphenyl)ethanone, 95.0%, 5g

4-Nitrobenzamide>98.0%(N)500g

2-Bromo-3-iodopyridine, 95.0%, 100g

(R)-1-(4-Bromobenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

7-BROMO-6-CHLORO-8-FLUOROQUINAZOLIN-4(3H)-ONE, 95.0%, 25g

Deuterium oxide, 99.9 at%D, 7.5 ml, glass packagingamp.

2,7-Dibromo-9H-thioxanthen-9-one, 98%, 100mg

Methyl3-formyl-1h-pyrrolo[2,3-b]pyridine-5-carboxylate, 98%, 1g

5-Chloro-1-methyl-1H-pyrazole-3-carboxylic acid, 97.0%, 5g